We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.63%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$59.8B
AUM Growth
+$5.07B
(+9.3%)
Cap. Flow
+$518M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
18.08%
Holding
2,992
New
38
Increased
2,358
Reduced
537
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$68M |
| 2 |
Truist Financial
TFC
|
+$55.9M |
| 3 |
ServiceNow
NOW
|
+$33.3M |
| 4 |
Uber
UBER
|
+$21.4M |
| 5 |
Las Vegas Sands
LVS
|
+$15.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$119M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$55.9M |
| 3 |
Apple
AAPL
|
+$48.3M |
| 4 |
iShares TIPS Bond ETF
TIP
|
+$22M |
| 5 |
VIAB
Viacom Inc. Class B
VIAB
|
+$16.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Financials | 15.53% |
| 3 | Healthcare | 13.38% |
| 4 | Consumer Discretionary | 10.07% |
| 5 | Industrials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Yelp
YELP
$1.47B
| $7.34M | 0.01% |
210,626
-3,352
| -2% | -$114K |
|
|
UHT
1027
Universal Health Realty Income Trust
UHT
$589M
| $7.32M | 0.01% |
62,386
+2,823
| +5% | +$321K |
|
1028
Rogers Corp
ROG
$2.36B
| $7.32M | 0.01% |
58,698
+3,480
| +6% | +$470K |
|
1029
Performance Food Group
PFGC
$17.7B
| $7.32M | 0.01% |
142,191
+5,648
| +4% | +$258K |
|
1030
Medpace
MEDP
$16.1B
| $7.3M | 0.01% |
86,906
+5,561
| +7% | +$430K |
|
1031
Genworth Financial
GNW
$3.76B
| $7.26M | 0.01% |
1,649,545
-27,628
| -2% | -$116K |
|
1032
AutoNation
AN
$7.15B
| $7.25M | 0.01% |
149,150
+1,013
| +0.7% | +$51.3K |
|
|
OPLN
1033
Openlane
OPLN
$4.27B
| $7.25M | 0.01% |
332,629
-19,133
| -5% | -$436K |
|
1034
Minerals Technologies
MTX
$2.33B
| $7.25M | 0.01% |
125,764
+1,515
| +1% | +$81.5K |
|
|
CUB
1035
DELISTED
Cubic Corporation
CUB
| $7.23M | 0.01% |
113,700
+7,934
| +8% | +$537K |
|
|
BBBY
1036
DELISTED
Bed Bath & Beyond Inc
BBBY
| $7.22M | 0.01% |
417,558
+1,007
| +0.2% | +$14.1K |
|
|
MDC
1037
DELISTED
M.D.C. Holdings, Inc.
MDC
| $7.22M | 0.01% |
204,292
+14,672
| +8% | +$552K |
|
1038
Trustmark
TRMK
$2.83B
| $7.21M | 0.01% |
209,057
+5,182
| +3% | +$179K |
|
1039
SPX Corp
SPXC
$10.8B
| $7.21M | 0.01% |
141,688
+10,391
| +8% | +$475K |
|
|
CMD
1040
DELISTED
Cantel Medical Corporation
CMD
| $7.21M | 0.01% |
101,627
+1,634
| +2% | +$119K |
|
|
RETA
1041
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $7.18M | 0.01% |
35,112
+3,880
| +12% | +$708K |
|
1042
Prestige Consumer Healthcare
PBH
$2.45B
| $7.16M | 0.01% |
176,835
+5,510
| +3% | +$206K |
|
1043
Quaker Houghton
KWR
$3B
| $7.15M | 0.01% |
43,475
+2,640
| +6% | +$409K |
|
1044
LivePerson
LPSN
$27.1M
| $7.14M | 0.01% |
12,861
+873
| +7% | +$501K |
|
1045
US Physical Therapy
USPH
$1.17B
| $7.13M | 0.01% |
62,398
+2,328
| +4% | +$290K |
|
|
CALY
1046
Callaway Golf Company
CALY
$3.5B
| $7.08M | 0.01% |
334,151
+20,251
| +6% | +$415K |
|
|
FLOW
1047
DELISTED
SPX FLOW, Inc.
FLOW
| $7.08M | 0.01% |
144,839
+7,149
| +5% | +$317K |
|
|
VRE
1048
DELISTED
Veris Residential
VRE
| $7.07M | 0.01% |
305,726
-4,048
| -1% | -$87.8K |
|
1049
Liberty Media Series C
FWONK
$24.3B
| $7.07M | 0.01% |
159,032
+1,842
| +1% | +$76.7K |
|
1050
Acadia Healthcare
ACHC
$2.92B
| $7.05M | 0.01% |
212,339
+76
| +0% | +$2.38K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2019 Portfolio in Review
As of Q4 2019, RhumbLine Advisers held 2,992 positions worth $59.8B, up 9.3% from $54.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 2.7%. RhumbLine Advisers opened 38 new positions and exited 43, leaving the 2,992-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2019 buy was Envista: 126,664 shares worth $3.75M.
- RhumbLine Advisers added most to Bristol-Myers Squibb in Q4 2019, an estimated $68M increase.
- RhumbLine Advisers's biggest Q4 2019 reduction was Apple, cutting an estimated $48.3M.
- RhumbLine Advisers fully exited Celgene Corp in Q4 2019, selling an estimated $119M.
- RhumbLine Advisers's ten largest holdings make up 18% of its $59.8B portfolio in Q4 2019.
- RhumbLine Advisers opened 38 new positions and closed 43 in Q4 2019.
- RhumbLine Advisers's portfolio value rose 9.3% quarter-over-quarter to $59.8B.
Based on RhumbLine Advisers's 13F filing for Q4 2019, filed 5 Feb 2020.